Trials / Unknown
UnknownNCT04083482
Removal of mtDNA in Plasma by Continous Venovenous Hemofiltration in Sepsis
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 20 (actual)
- Sponsor
- First People's Hospital of Chenzhou · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
The plasma level of mtDNA in sepsis is affected by continous venovenous hemofiltation（CVVH）
Detailed description
Continous renal replacement therapy （CRRT）has become routine for patients with chronic renal failure ，AKI，fliud overload as well as oliguria in ICU .In clinical patients ，continous venovenous hemofoiltration （CVVH）is actually the method of chioce for CRRT in critically ill and hemodynamic instable patients .CVVH has significant beneficial effects on removing inflammatory cytokines ，improving oxygen index，increasing cardiac index and regulating immune dysfuntion .
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | continous venovenous hemofiltraion | CVVH |
Timeline
- Start date
- 2018-08-20
- Primary completion
- 2018-09-20
- Completion
- 2019-12-31
- First posted
- 2019-09-10
- Last updated
- 2019-09-10
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT04083482. Inclusion in this directory is not an endorsement.